News + Press

Patient Support Programs—Providing Help Beyond Financial Support

Posted September 21, 2018| Fuld + Company

Varun Naik was called upon by PM360 to share best practices on Effectively Developing a Patient Support Program by Leveraging Competitive Intelligence (CI) tactics. He also covers this topic broadly in a Fuld + Company whitepaper.

Patient Support Programs | Varun Naik, Fuld + Company

An effective PSP is critical to a drug’s success and requires significant resources to develop and manage.

Therefore, organizations must make the right investment decisions with a focus on the patient’s needs, especially as patients play a stronger role in their treatment decisions. Executives must also identify elements that create exceptional value for patients and meet the needs of healthcare offices.

Developing a robust strategy for a patient support program begins with assessing the current environment.

By benchmarking existing programs and pinpointing their areas of improvement, companies can leverage insights to refine their approach and create a competitive advantage. While all programs tend to include the same basic elements, there is no one size fits all approach, as experiences differ by indication. However, some success criteria Fuld + Company has identified for all patient support programs are…

 

 

About Varun Naik

Varun Naik serves as Director in the Life Science Consulting practice at Fuld + Company. He specializes in rare disease, biosimilars and other pharma related topics.

Tags: , , ,

Related Resources

Read More

Fuld + Company Announces New, Senior Hire for Energy Practice

Keith McWhorter, MBA, Brings Strong Domain Knowledge, Strategy, Analysis and Research Capabilities to the Firm Boston, Mass. July 11, 2019—Fuld […]

Read More

Analysis Of The Trastuzumab Biosimilar Market As Herceptin Exclusivity Nears An End

To expand on the Fuld + Company, Pharma Companies to Watch Report, Analyst Robert Browne drilled in on the Biosimilar Marketplace in […]

Read More

Evolution In Prostate Cancer Diagnostics Creates New Opportunities For Medtech

In the US, prostate cancer remains a challenge for men’s health, with approximately 174,650 new cases expected in 2019, third […]

Subscribe to our mailing list for our latest updates: